RecruitingNCT07420907
Study of the Progression of Chronic Cardiovascular Conditions
A Non-interventional Observational Study of the Sustained Use of Prolaio Digital Health Devices to Monitor the Natural History of Chronic Cardiovascular Conditions in Ambulatory Patients
Sponsor
Prolaio
Enrollment
5,000 participants
Start Date
Oct 30, 2025
Study Type
OBSERVATIONAL
Conditions
Heart FailureHypertensionDilated CardiomyopathyHypertension (HTN)Aortic StenosisCardiovascular Disease (CVD)Aortic Stenosis DiseaseHypertrophic Cardiomyopathy PatientsHypertrophic Cardiomyopathy Without ObstructionHypertrophic Cardiomyopathy, ObstructiveDilated Cardiomyopathy (DCM)Dilated Cardiomyopathy, Familial
Summary
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- years of age and older
- Ability to understand study assessments and give informed consent to data collection
- Ability to comply with the study protocol
- Ability to understand and respond to instructions in English
- Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc.
- Resides in the United States
Exclusion Criteria4
- Allergy to adhesive used in biosensor patch
- Life threatening disease process outside of area under study, such as actively treated cancer or pre/post-transplant such as hepatic failure; end-stage renal disease.
- Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV
- Self-reported weight of 400 pounds or greater
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07420907
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations